Skip to content

Analysis of risk factors for surgical site infection in patients receiving neoadjuvant therapy for lung cancer and construction of prediction model to guide the rational application of antibiotics

Analysis of risk factors for surgical site infection in patients receiving neoadjuvant therapy for lung cancer and construction of prediction model to guide the rational application of antibiotics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036932
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Site Infection

Interventions

neoadjuvant therapy group vs non neoadjuvant therapy group:Nil
infection group vs non infection:Nil

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: Same criteria: 1. Cases with complete medical history; 2. The selected products for preventive use of antibiotics were the first generation cefazolin or the second generation cefoxime, and the dose and course of treatment were in line with the Guidelines for Clinical Application of Antibiotics (2015 edition); 3. The timing of prophylactic use of antimicrobial agents was 0.5-2h before operation; 4. Operation duration < 3 hours, and intraoperative blood loss < 1500mL. Different criteria: 1. Case group: cases receiving neoadjuvant therapy (including chemotherapy, targeting or immunization). 2. Control group: patients without neoadjuvant therapy.

Exclusion criteria

Exclusion criteria: 1. Cases of allergy to -lactam antibiotics; 2. The course of prophylactic use of antibiotics without postoperative infection is >= 48 hours; 3. Patients who received non-prophylactic antimicrobial therapy after the operation were asymptomatic; 4. Neoadjuvant therapy regimens containing radiotherapy; 5. Cases treated with antibiotics 2 weeks before operation; 6. Pet-type cases with severe insufficiency of liver and kidney function; 7. The case of secondary surgery on the lung.

Design outcomes

Primary

MeasureTime frame
DDDs of antibiotics use during hospitalization;

Secondary

MeasureTime frame
Proportion of antibiotics used in special use grade;

Countries

China

Contacts

Public ContactYu Jianguang

Shanghai Chest Hospital

yueqingqiu@163.com+86 13764159445

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026